Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Raised levels of P/Q type voltage-gated calcium-channel (VGCC) antibodies were found in 16 (41%) of 39 patients with paraneoplastic cerebellar degeneration (PCD) and Hu antibodies were found in nine (23%). Seven of the 16 VGCC antibody-positive patients had Lambert-Eaton myasthenic syndrome (LEMS). Seven of 15 CSF samples had VGCC antibodies, with evidence of intrathecal synthesis in four. VGCC antibodies should be looked for in PCD, even if there are no symptoms of LEMS, and may be related to the cerebellar dysfunction.


Journal article



Publication Date





764 - 766


Animals, Autoantibodies, Biomarkers, Calcium Channels, N-Type, Cerebellum, ELAV Proteins, Female, Humans, Lambert-Eaton Myasthenic Syndrome, Lung Neoplasms, Male, Middle Aged, Nerve Tissue Proteins, Paraneoplastic Cerebellar Degeneration, RNA-Binding Proteins, Rats